Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Kapp

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Best Practice & Research. Clinical Haematology|September 20, 2011
Adoptive immunotherapy with virus-specific T cellsShigeo Fuji, Markus Kapp, Götz Ulrich Grigoleit, et al.
Current Opinion in Organ Transplantation|October 9, 2010
T-cell therapy for cytomegalovirus infectionTan S Mui, Markus Kapp, Hermann Einsele, et al.
Case Reports in Oncology|March 3, 2016
Exceptional Response to Nanoparticle Albumin-Bound Paclitaxel and Gemcitabine in a Patient with a Refractory Adenocarcinoma of the Ampulla of VaterMarkus Kapp, Aleksander Kosmala, Stefan Kircher, et al.
Clinical Transplantation|October 8, 2014
Improvement of quality of life in patients with steroid-refractory chronic graft-versus-host disease treated with the mTOR inhibitor everolimusMathias Lutz, Markus Kapp, Hermann Einsele, et al.
Case Reports in Oncology|November 20, 2014
Intensified Neoadjuvant Chemotherapy with Nab-Paclitaxel plus Gemcitabine Followed by FOLFIRINOX in a Patient with Locally Advanced Unresectable Pancreatic CancerVolker Kunzmann, Ken Herrmann, Christina Bluemel, et al.
The Journal of Infectious Diseases|August 4, 2007
Dendritic cell vaccination in allogeneic stem cell recipients: induction of human cytomegalovirus (HCMV)-specific cytotoxic T lymphocyte responses even in patients receiving a transplant from an HCMV-seronegative donorGotz Ulrich Grigoleit, Markus Kapp, Holger Hebart, et al.
Cytotherapy|January 22, 2011
Uptake of antigens from modified vaccinia Ankara virus-infected leukocytes enhances the immunostimulatory capacity of dendritic cellsChristin Flechsig, Yasemin Suezer, Markus Kapp, et al.
Plos One|July 9, 2011
SMAC mimetic BV6 induces cell death in monocytes and maturation of monocyte-derived dendritic cellsNicole Müller-Sienerth, Lena Dietz, Philipp Holtz, et al.
Leukemia & Lymphoma|November 6, 2009
Clofarabine-based salvage chemotherapy for relapsed or refractory acute leukemia before allogeneic stem cell transplantation: results from a case seriesGötz Ulrich Grigoleit, Markus Kapp, Sen Mui Tan, et al.
Annals of Hematology|January 31, 2012
Features of extramedullary myeloma relapse: high proliferation, minimal marrow involvement, adverse cytogenetics: a retrospective single-center study of 24 casesLeo Rasche, Corinna Bernard, Max S Topp, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Best Practice & Research. Clinical Haematology|September 20, 2011
Adoptive immunotherapy with virus-specific T cellsShigeo Fuji, Markus Kapp, Götz Ulrich Grigoleit, et al.
Current Opinion in Organ Transplantation|October 9, 2010
T-cell therapy for cytomegalovirus infectionTan S Mui, Markus Kapp, Hermann Einsele, et al.
Case Reports in Oncology|March 3, 2016
Exceptional Response to Nanoparticle Albumin-Bound Paclitaxel and Gemcitabine in a Patient with a Refractory Adenocarcinoma of the Ampulla of VaterMarkus Kapp, Aleksander Kosmala, Stefan Kircher, et al.
Clinical Transplantation|October 8, 2014
Improvement of quality of life in patients with steroid-refractory chronic graft-versus-host disease treated with the mTOR inhibitor everolimusMathias Lutz, Markus Kapp, Hermann Einsele, et al.
Case Reports in Oncology|November 20, 2014
Intensified Neoadjuvant Chemotherapy with Nab-Paclitaxel plus Gemcitabine Followed by FOLFIRINOX in a Patient with Locally Advanced Unresectable Pancreatic CancerVolker Kunzmann, Ken Herrmann, Christina Bluemel, et al.
The Journal of Infectious Diseases|August 4, 2007
Dendritic cell vaccination in allogeneic stem cell recipients: induction of human cytomegalovirus (HCMV)-specific cytotoxic T lymphocyte responses even in patients receiving a transplant from an HCMV-seronegative donorGotz Ulrich Grigoleit, Markus Kapp, Holger Hebart, et al.
Cytotherapy|January 22, 2011
Uptake of antigens from modified vaccinia Ankara virus-infected leukocytes enhances the immunostimulatory capacity of dendritic cellsChristin Flechsig, Yasemin Suezer, Markus Kapp, et al.
Plos One|July 9, 2011
SMAC mimetic BV6 induces cell death in monocytes and maturation of monocyte-derived dendritic cellsNicole Müller-Sienerth, Lena Dietz, Philipp Holtz, et al.
Leukemia & Lymphoma|November 6, 2009
Clofarabine-based salvage chemotherapy for relapsed or refractory acute leukemia before allogeneic stem cell transplantation: results from a case seriesGötz Ulrich Grigoleit, Markus Kapp, Sen Mui Tan, et al.
Annals of Hematology|January 31, 2012
Features of extramedullary myeloma relapse: high proliferation, minimal marrow involvement, adverse cytogenetics: a retrospective single-center study of 24 casesLeo Rasche, Corinna Bernard, Max S Topp, et al.
Pageof 3